Evidence map›Paper›PMID 25598735›Full record

ReviewOchsner journal2014

Functional genomics in the study of mind-body therapies.

Halsey Niles, Darshan H Mehta, Alexandra A Corrigan, Manoj K Bhasin, John W Denninger

Abstract readReview
In one paragraph

Review in Ochsner journal, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Childhood Maltreatment and Health Impact: The Examples of Cardiovascular Disease and Type 2 Diabetes Mellitus in Adults.Clinical psychology : a publication of the Division of Clinical Psychology of the American Psychological Association · 2017
    Article
  13. Epigenetic Advances in Behavioral and Brain Sciences have Relevance for Public Policy.Policy insights from the behavioral and brain sciences · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Halsey NilesBenson-Henry Institute for Mind Body Medicine, Massachusetts General Hospital, Boston, MA.
Darshan H MehtaBenson-Henry Institute for Mind Body Medicine, Massachusetts General Hospital, Boston, MA ; Department of Medicine, Massachusetts General Hospital, Boston, MA.
Alexandra A CorriganBenson-Henry Institute for Mind Body Medicine, Massachusetts General Hospital, Boston, MA.
Manoj K BhasinBenson-Henry Institute for Mind Body Medicine, Massachusetts General Hospital, Boston, MA ; Genomics and Proteomics Core, Beth Israel Deaconess Medical Center, Boston, MA.
John W DenningerBenson-Henry Institute for Mind Body Medicine, Massachusetts General Hospital, Boston, MA ; Department of Psychiatry, Massachusetts General Hospital, Boston, MA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMind-body therapies (MBTs) are used throughout the world in treatment, disease prevention, and health promotion. However, the mechanisms by which MBTs exert their positive effects are not well understood. Investigations into MBTs using functional genomics have revolutionized the understanding of MBT mechanisms and their effects on human physiology.

methodsWe searched the literature for the effects of MBTs on functional genomics determinants using MEDLINE, supplemented by a manual search of additional journals and a reference list review.

resultsWe reviewed 15 trials that measured global or targeted transcriptomic, epigenomic, or proteomic changes in peripheral blood. Sample sizes ranged from small pilot studies (n=2) to large trials (n=500). While the reliability of individual genes from trial to trial was often inconsistent, genes related to inflammatory response, particularly those involved in the nuclear factor-kappa B (NF-κB) pathway, were consistently downregulated across most studies.

conclusionIn general, existing trials focusing on gene expression changes brought about by MBTs have revealed intriguing connections to the immune system through the NF-κB cascade, to telomere maintenance, and to apoptotic regulation. However, these findings are limited to a small number of trials and relatively small sample sizes. More rigorous randomized controlled trials of healthy subjects and specific disease states are warranted. Future research should investigate functional genomics areas both upstream and downstream of MBT-related gene expression changes-from epigenomics to proteomics and metabolomics.

Indexed as

Epigenomicsgene expressionmind-body therapiesNF-kappa Bproteomics

Identifiers

PMID25598735
PMCPMC4295747

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.